Cruveilhier–Baumgarten disease

From WikiMD's WELLNESSPEDIA


Cruveilhier–Baumgarten disease
Synonyms Cruveilhier-Baumgarten syndrome
Pronounce N/A
Specialty Gastroenterology
Symptoms Abdominal pain, ascites, varices, caput medusae
Complications Portal hypertension, esophageal varices
Onset
Duration
Types
Causes Portal hypertension, liver cirrhosis
Risks
Diagnosis Physical examination, Doppler ultrasound, CT scan
Differential diagnosis Budd-Chiari syndrome, hepatic veno-occlusive disease
Prevention
Treatment Beta blockers, endoscopic band ligation, transjugular intrahepatic portosystemic shunt (TIPS)
Medication Propranolol, nadolol
Prognosis
Frequency
Deaths


Cruveilhier–Baumgarten disease is a rare medical condition characterized by the presence of portal hypertension without the occurrence of liver cirrhosis. The disease was first described by French pathologist Jean Cruveilhier and German pathologist Paul Clemens von Baumgarten, hence the name.

Etymology[edit]

The disease is named after Jean Cruveilhier (1791–1874), a French pathologist who was a professor of pathological anatomy at the University of Paris, and Paul Clemens von Baumgarten (1848–1928), a German pathologist who was a professor at the University of Tübingen.

Symptoms[edit]

The main symptom of Cruveilhier–Baumgarten disease is portal hypertension, which is high blood pressure in the portal vein. This can lead to various complications, including esophageal varices, splenomegaly, and ascites. Other symptoms may include caput medusae, which is the appearance of distended and engorged superficial epigastric veins, and a positive Cruveilhier-Baumgarten bruit, which is a venous hum heard in the epigastric region or over the liver.

Diagnosis[edit]

Diagnosis of Cruveilhier–Baumgarten disease is typically made through a combination of clinical examination and imaging studies. Ultrasound, CT scan, and MRI may be used to visualize the liver and portal vein. In some cases, a liver biopsy may be performed to rule out cirrhosis.

Treatment[edit]

Treatment for Cruveilhier–Baumgarten disease primarily involves managing the symptoms and complications of portal hypertension. This may include medications to lower blood pressure, endoscopic procedures to treat esophageal varices, and in severe cases, liver transplantation.

Prognosis[edit]

The prognosis for individuals with Cruveilhier–Baumgarten disease varies depending on the severity of portal hypertension and the presence of other underlying conditions. With appropriate management, many individuals can live a normal lifespan.

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.